New Edge Advisors, LLC Vista Gen Therapeutics, Inc. Transaction History

New Edge Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$1.96 - $3.15 $43,708 - $70,245	-22,300 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$1.89 - $2.96 $5,670 - $8,880	3,000 Added 15.54%	22,300 $47,000
Q4 2020 Jan 27, 2021	BUY	$0.65 - $1.94 $4,745 - $14,162	7,300 Added 60.83%	19,300 $37,000
Q3 2020 Nov 03, 2020	BUY	$0.48 - $1.03 $5,760 - $12,360	12,000 New	12,000 $8,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $623M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on New Edge Advisors, LLC with notifications on news.